Clinical correlates of grey matter pathology in multiple sclerosis by Horakova Dana, Kalincik Tomas, Blahova Dusankova Jana, Dolezal Ondrej

Get full text

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis by Daniel Merlo, David Darby, Tomas Kalincik, Helmut Butzkueven, Anneke van der Walt

Get full text

Sample Entropy Improves Assessment of Postural Control in Early-Stage Multiple Sclerosis by L. Eduardo Cofré Lizama, Xiangyu He, Tomas Kalincik, Mary P. Galea, Maya G. Panisset

Get full text

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study. by Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova

Get full text

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study by Tomas Kalincik, Andrew Evans, Thanuja Dharmadasa, Elise White, Belinda Cruse, Sifat Sharmin, Callum Hollis, Lynette Kiers

Get full text

Contactin 2 and contactin-associated protein 2 antibodies in patients with multiple sclerosis and clinically isolated syndrome by Nytrova, P, Waters, P, Horakova, D, Hacohen, Y, Kalincik, T, Zbornikova, P, Blahova, J, Krasensky, J, Vaneckova, M, Havrdova, E, Wandinger, K, Vincent, A

Modelling accessibility of adult neurology care in Australia, 2020–2034 by Tomas Kalincik, Merrilee Needham, Steve Simpson-Yap, Christian Lueck, Nicholas Child, Federico Frascoli, Charles Malpas, Benjamin Tsang, James Burrell, Lucinda Harrison, Lauren P Giles

Get full text

Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with mul... by Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincik, Leonid Churilov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil O’Brien-Simpson, Anneke Van Der Walt, Lisa Taylor

Get full text

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium by James Broadley, James Broadley, Robb Wesselingh, Robb Wesselingh, Udaya Seneviratne, Udaya Seneviratne, Udaya Seneviratne, Chris Kyndt, Chris Kyndt, Paul Beech, Paul Beech, Katherine Buzzard, Katherine Buzzard, Cassie Nesbitt, Cassie Nesbitt, Wendyl D’Souza, Wendyl D’Souza, Amy Brodtmann, Amy Brodtmann, Tomas Kalincik, Tomas Kalincik, Helmut Butzkueven, Helmut Butzkueven, Terence J. O’Brien, Terence J. O’Brien, Mastura Monif, Mastura Monif, Mastura Monif, Mastura Monif, Australian Autoimmune Encephalitis Consortium

Get full text

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Austral... by Vicki E Maltby, Rodney A Lea, Mastura Monif, Marzena J Fabis-Pedrini, Katherine Buzzard, Tomas Kalincik, Allan G Kermode, Bruce Taylor, Suzanne Hodgkinson, Pamela McCombe, Helmut Butzkueven, Michael Barnett, Jeannette Lechner-Scott

Get full text

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies by Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman

Get full text

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study by Michael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, Helmut Butzkueven, Tomas Kalincik, Patricia Desmond, Frank Gaillard, Vincent van Pesch, Serkan Ozakbas, Juan Ignacio Rojas, Cavit Boz, Ayse Altintas, Chenyu Wang, Michael G. Dwyer, Suzie Yang, Dejan Jakimovski, Kain Kyle, Deepa P. Ramasamy, Robert Zivadinov

Get full text

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. by Dana Horakova, Robert Zivadinov, Bianca Weinstock-Guttman, Eva Havrdova, Jun Qu, Miriam Tamaño-Blanco, Darlene Badgett, Michaela Tyblova, Niels Bergsland, Sara Hussein, Laura Willis, Jan Krasensky, Manuela Vaneckova, Zdenek Seidl, Petra Lelkova, Michael G Dwyer, Ming Zhang, Haoying Yu, Xiaotao Duan, Tomas Kalincik, Murali Ramanathan

Get full text

Predictors of treatment switching in the Big Multiple Sclerosis Data Network by Tim Spelman, Tim Spelman, Melinda Magyari, Melinda Magyari, Helmut Butzkueven, Helmut Butzkueven, Anneke Van Der Walt, Anneke Van Der Walt, Sandra Vukusic, Sandra Vukusic, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP

Get full text

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis by M. Lefort, S. Sharmin, J. B. Andersen, S. Vukusic, R. Casey, M. Debouverie, G. Edan, J. Ciron, A. Ruet, J. De Sèze, E. Maillart, H. Zephir, P. Labauge, G. Defer, C. Lebrun-Frenay, T. Moreau, E. Berger, P. Clavelou, J. Pelletier, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, J. P. Camdessanché, A. Maurousset, H. Ben Nasr, K. Hankiewicz, C. Pottier, N. Maubeuge, D. Dimitri-Boulos, C. Nifle, D. A. Laplaud, D. Horakova, E. K. Havrdova, R. Alroughani, G. Izquierdo, S. Eichau, S. Ozakbas, F. Patti, M. Onofrj, A. Lugaresi, M. Terzi, P. Grammond, F. Grand’Maison, B. Yamout, A. Prat, M. Girard, P. Duquette, C. Boz, M. Trojano, P. McCombe, M. Slee, J. Lechner-Scott, R. Turkoglu, P. Sola, D. Ferraro, F. Granella, V. Shaygannejad, J. Prevost, D. Maimone, O. Skibina, K. Buzzard, A. Van der Walt, R. Karabudak, B. Van Wijmeersch, T. Csepany, D. Spitaleri, S. Vucic, N. Koch-Henriksen, F. Sellebjerg, P. S. Soerensen, C. C. Hilt Christensen, P. V. Rasmussen, M. B. Jensen, J. L. Frederiksen, S. Bramow, H. K. Mathiesen, K. I. Schreiber, H. Butzkueven, M. Magyari, T. Kalincik, E. Leray

Get full text